Portage Biotech Inc. (PRTG) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Portage Biotech Inc.

    NASDAQ: PRTG · Real-Time Price · USD
    6.81
    -0.15 (-2.16%)
    At close: Sep 03, 2025, 3:59 PM
    7.52
    10.43%
    After-hours: Sep 03, 2025, 07:59 PM EDT

    Portage Biotech Income Statement

    Financials in USD. Fiscal year is April - March.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 54K 1K n/a n/a
    Gross Profit
    		 -54K -1K n/a n/a
    Operating Income
    		 -18.25M -16.57M -15.59M -12.44M
    Interest Income
    		 274K 217K 43.00 177.00
    Pretax Income
    		 -85.7M -122.52M -14.82M -14.89M
    Net Income
    		 -75.34M -104.61M -16.87M -15.83M
    Selling & General & Admin
    		 5.66M 8.36M 8.82M 5.13M
    Research & Development
    		 12.54M 8.21M 6.77M 7.31M
    Other Expenses
    		 n/a 1K n/a n/a
    Operating Expenses
    		 18.2M 16.58M 15.59M 12.44M
    Interest Expense
    		 32K 9K 43K 177K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 18.25M 16.58M 15.59M 12.44M
    Income Tax Expense
    		 -10.55M -17.86M 4.35M 2.3M
    Shares Outstanding (Basic)
    		 20.34M 16.12M 13.06M 11.73M
    Shares Outstanding (Diluted)
    		 20.34M 16.12M 13.06M 11.73M
    EPS (Basic)
    		 -3.7 -6.49 -1.29 -1.35
    EPS (Diluted)
    		 -3.7 -6.49 -1.29 -1.35
    EBITDA
    		 -18.2M -15.78M -15.59M -14.19M
    EBIT
    		 -18.25M -15.78M -14.71M -14.22M
    Depreciation & Amortization
    		 54K 1K 15.59M 12.24M

    Add to Watchlist